Bullish Stock Trend Analysis: National Bank of Greece, Microsoft Corporation,
Aetrium, Echo Therapeutics, Twitter Inc
NEW YORK, December 2, 2013
NEW YORK, December 2, 2013 /PRNewswire/ --
Market Buzz Report, engaged in providing penny stock alerts, issues notable
stock analysis for National Bank of Greece (NYSE:NBG), Microsoft Corporation
(NASDAQ:MSFT), Aetrium, Inc. (NASDAQ:ATRM), Echo Therapeutics Inc
(NASDAQ:ECTE), Twitter Inc (NYSE:TWTR).
National Bank of Greece (NYSE:NBG) shares climbed 6.27% to $6.27. The company
on Nov. 25 said it has agreed to sell a majority stake in its real estate arm
Pangaia to private equity firm Invel Real Estate in a 653 million-euro ($882
million) deal. The sale, which was revealed, last week, is part of a
restructuring by National Bank (NBG) aimed at boosting its capital base.
Free Urgent Insider Catalyst Report For NBG Available
Here:http://marketbuzzreport.com/index.php?code=NBG(Or Copy and paste the
URL into your browser)
Under the terms of the latest deal Invel will acquire 66 percent of Pangaia,
NBG said in a statement, and will pay 161 million in cash, contribute equity
in the form of real estate and also take out a loan from NBG.
Microsoft Corporation (NASDAQ:MSFT) shares increased 1.41% to $38.13. The
company on Nov. 19 announced that its board of directors declared a quarterly
dividend of $0.28 per share. The dividend is payable March 13, 2014 to
shareholders of record on February 20, 2014. The ex-dividend date will be
February 18, 2014.
Free Urgent Insider Catalyst Report For MSFT Available Here:
http://marketbuzzreport.com/index.php?code=MSFT(Or Copy and paste the URL
into your browser)
Additionally, the company on Nov. 8 announced participation in the following
upcoming events with the financial community. Interested parties can listen to
a webcast of these events on Microsoft's Investor Relations website: UBS
Global Technology Conference on Thursday, November 21, 2013 at 8:30 a.m.
Shares of Aetrium, Inc. (NASDAQ:ATRM) surged 150% last week after SA
contributor Small-Cap Momentum Advisors pens the bull case, arguing that
shares should be valued at $15-$20.The author bases the thesis on a recent
management shake-up that saw activist Jeffrey Eberwein appointed Chairman.
Eberwein and his fund, Lone Star Investors, have a 5.6% stake in ATRM.Q1, the
author says, "should be a monumental turnaround quarter," with the company
booking revenues of a previously-announced $2.1M order by the quarter's end.
The order alone represents almost 2x Q1 2013 revenue, and is indicative of
"significant traction," the author notes.
Free Urgent Insider Catalyst Report For ATRM Available Here:
http://marketbuzzreport.com/index.php?code=ATRM(Or Copy and paste the URL
into your browser)
Shares of Echo Therapeutics Inc (NASDAQ:ECTE) soared nearly 65% to $3.83 last
week following the release of positive results of its study on wireless
glucose monitoring system, Symphony CGM. The study revealed that Symphony is
capable of monitoring glucose levels as it did on 32 patients in critical care
units at four hospitals. The Continuous Glucose-Error Grid Analysis showed
that readings in Symphony CGM were 97.9% accurate and 1.8% were benign errors,
with a combined A+B value of 99.7%. The glucose values range was 49 to 324
Free Urgent Insider Catalyst Report For ECTE Available Here:
http://marketbuzzreport.com/index.php?code=ECTE(Or Copy and paste the URL
into your browser)
Though still below its opening price of $45.10, Twitter Inc (NYSE:TWTR) has
rallied 6% from its Monday close of $39.06. The gains come ahead of Monday
coverage launches from the company's IPO underwriters. If history is any
guide, bullish reports should easily outweigh bearish ones; the investor
reaction might depend a lot on how upbeat analysts are in the face of a
valuation that's still around ~40x 2013E sales (after factoring options/RSUs).
Ahead of the launches, Twitter has picked up four bullish ratings, eight
neutral ones, and three bearish ones non-underwriting firms. The
neutral/bearish arguments almost uniformly revolve around Twitter's multiples.
Wunderlich, which is reiterating a Sell, notes pre-IPO underwriter estimates
were well below current consensus forecasts. The firm is reiterating a $34 PT,
and maintaining a subdued view of Twitter's efforts to sell ads to TV
advertisers and e-commerce firms.
Free Urgent Insider Catalyst Report For TWTR Available Here:
http://marketbuzzreport.com/index.php?code=TWTR(Or Copy and paste the URL
into your browser)
USMarketBuzz.com is an investment community that Focuses on MicroCap
Securities. USMarketBuzz.com is an authorative authentic Google News Site and
Leading Provider of Investment Awareness and Featured Company Profiles. If you
would like more information regarding our news coverage solutions, please
visit http://www.USMarketBuzz.com/for more details. Get an edge on the market
with our Premium News Alerts that are FREE for a limited time at
http://www.USMarketBuzz.com/. Follow us on Facebook:
https://www.facebook.com/usmarket.buzz. Sign up for our FREE SMS News alerts
delivered directly to your mobile phone by texting the word PREPROMO to 27126.
(SMS alerts are free, however data rates may apply, check your wireless plan
DISCLAIMER: FNNewswire (FNNW) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNNW is NOT affiliated in any manner
with MarketBuzz Reports, USMarketBuzz.com or any company mentioned herein.
The commentary, views and opinions expressed in this release by MarketBuzz
Reports and USMarketBuzz.com are solely those of the MarketBuzz Reports &
USMarketBuzz.com and are not shared by and do not reflect in any manner the
views or opinions of FNNW. The companies that are discussed herein may or may
not have approved the statements made in this release. FNNW is not liable for
any investment decisions by its readers or subscribers FNNW and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNNW
was not compensated by any public company mentioned herein to disseminate this
FNNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNNW undertakes no obligation to update such statements.
FNNW Contact Information:
Company: FN Newswire
Contact email: email@example.com
SOURCE FN Media Group LLC
Press spacebar to pause and continue. Press esc to stop.